Author

L. J. Goudswaard

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

I. Hers· 2 shared K. J. Heesom· 2 shared A. D. Davidson· 1 shared A. Milne· 1 shared A. Munkacsi· 1 shared A. W. Poole· 1 shared B. Nabet· 1 shared C. M. Williams· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

I. Hers

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivPreprintOct 12, 2022

Alterations in platelet proteome signature and impaired platelet integrin αIIbβ3 activation in patients with COVID-19

L. J. Goudswaard, C. M. Williams, J. Khalil…·I. Hers

This study identifies altered platelet proteome and impaired integrin αIIbβ3 activation in COVID-19 patients, linked to increased platelet-neutrophil aggregates and thromboinflammation.

DOI 10.1101/2022.10.12.511145

humanproteomics

𝕏 PostBluesky

Cell BiologybioRxivPreprintMay 30, 2022

Chemical degradation of BTK/TEC as a novel approach to inhibit platelet function and thrombosis.

J. S. Trory, A. Munkacsi, K. Sledz…·I. Hers

This study shows that chemical degradation of BTK/TEC in human platelets reduces thrombotic function without affecting PAR-1-mediated responses.

DOI 10.1101/2022.05.30.493973

humanexperimental assay

𝕏 PostBluesky